Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

100%(1 trials)

Phase Distribution

Ph phase_4

50%

Ph not_applicable

25%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

Phase 4Post-market surveillance

2(50.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(1)

Other(2)

Detailed Status

unknown2

Withdrawn1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 31 (25.0%)

Phase 42 (50.0%)

N/A1 (25.0%)

Trials by Status

withdrawn125%

completed125%

unknown250%

Recent Activity

0 active trials

Showing 4 of 4

withdrawnnot_applicable

The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis

NCT01936194

completedphase_3

Age-Related Eye Disease Study 2 (AREDS2)

NCT00345176

unknownphase_4

Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia

NCT01480687

unknownphase_4

Effects of Omega-3 Fatty Acids on Bone and Frailty

NCT00634686

Clinical Trials (4)

Showing 4 of 4 trials

NCT01936194Not Applicable

The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis

Withdrawn

NCT00345176Phase 3

Age-Related Eye Disease Study 2 (AREDS2)

Completed

NCT01480687Phase 4

Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia

Unknown

NCT00634686Phase 4

Effects of Omega-3 Fatty Acids on Bone and Frailty

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 4